• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC NEUROSURGERY STRATAMR ADJUSTABLE PRESSURE VALVE; SHUNT, CENTRAL NERVOUS SYSTEM AND COMPONENTS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC NEUROSURGERY STRATAMR ADJUSTABLE PRESSURE VALVE; SHUNT, CENTRAL NERVOUS SYSTEM AND COMPONENTS Back to Search Results
Model Number 42965
Device Problems Nonstandard Device (1420); Therapeutic or Diagnostic Output Failure (3023)
Patient Problems Headache (1880); Blurred Vision (2137)
Event Date 05/16/2022
Event Type  Injury  
Event Description
I had the strata mr vp shunt implanted on (b)(6) 2016.Two months later, the mr recall letter went out - the mr was adjusted from 2.0 to 0.5 within 6 months.In 2020, i had a ct of my sinuses whereby the ent saw a pocket of fluid and sent me to (b)(6) neurosurgeon (b)(6).Dr.(b)(6) determined the shunt was overdraining, and set the valve to 1.5.Fast-forward two years, and i started having headaches and blurry vision again.Newest ct scans showed my ventricles considerably larger than they were in the 2020 scans.I stayed overnight in the er at (b)(6) on (b)(6) they first adjusted my shunt down to 0.5 again, then in the morning, set it to 1.0.A month later, the shunt setting was fluctuating between 1.0 and 1.5.Dr.(b)(6) did an exploratory surgery and determined the strata mr to be completely non-functional.On monday, (b)(6), he replaced the strata mr with a strata ii valve.Fda safety report id # (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STRATAMR ADJUSTABLE PRESSURE VALVE
Type of Device
SHUNT, CENTRAL NERVOUS SYSTEM AND COMPONENTS
Manufacturer (Section D)
MEDTRONIC NEUROSURGERY
MDR Report Key14494916
MDR Text Key292961824
Report NumberMW5109894
Device Sequence Number1
Product Code JXG
UDI-Device Identifier00643169692701
UDI-Public(01)00643169692701(17)190531(10)
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Patient
Type of Report Initial
Report Date 05/21/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/24/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Model Number42965
Device Lot NumberE12952
Was Device Available for Evaluation? No
Patient Sequence Number1
Treatment
300MG GABAPENTIN - 3X DAILY; BENADRYL; CALCIUM; FISH OIL; FLEXERIL - 5MG DAILY; GLUCOSAMINE CHONDROITIN; LIPITOR - 40MG DAILY; LISINOPRIL 20MG DAILY; NORVASC - 5MG DAILY; ONE-A-DAY WOMEN'S; PROZAC - 10MG DAILY; STRATA II ADJUSTABLE PRESSURE VALVE
Patient Outcome(s) Hospitalization;
Patient Age51 YR
Patient SexFemale
Patient Weight77 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-